CANF Competitors & Alternatives
Compare Can Fite Biopharma Ltd ADR with similar stocks in the same industry
Biotechnology
CANF
Main Stock$3.26
Tradestie Score
47
Market Cap
$9.67M
Revenue Growth
-0.4%
Analyst Upside
+145.4%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PRLD
Prelude Therapeutics Incorporated
|
$6.60
|
$85.47M | - | 36 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.41
|
$84.52M | - | 49 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.60
|
$71.69M | - | 56 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.53
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.65
|
$67.94M | - | 34 | Compare |
|
BLRX
BioLineRX Ltd
|
$2.91
|
$16.50M | - | 51 | Compare |
|
RDHL
Redhill Biopharma Ltd.
|
$0.61
|
$8.39M | - | 50 | Compare |
|
CETX
CEMTREX INC.
|
$2.66
|
$4.26M | - | 42 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
More CANF Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
242 stocks in this industry